Evidence map›Paper›PMID 24322617›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2014

Novel role of transient receptor potential vanilloid 2 in the regulation of cardiac performance.

Jack Rubinstein, Valerie M Lasko, Sheryl E Koch, Vivek P Singh, Vinicius Carreira, Nathan Robbins, Amit R Patel, Min Jiang, Philip Bidwell, Evangelia G Kranias and 2 more

Abstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Vascular mechanotransduction.Physiological reviews · 2023
    Review
  10. Article
  11. Effects of Sarcolemmal Background CaFrontiers in physiology · 2022
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Tsg101 positively regulates physiologic-like cardiac hypertrophy through FIP3-mediated endosomal recycling of IGF-1R.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  18. Article
  19. Review
  20. A novel human S10F-Hsp20 mutation induces lethal peripartum cardiomyopathy.Journal of cellular and molecular medicine · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Jack RubinsteinDivision of Cardiovascular Diseases, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio;
Valerie M Lasko
Sheryl E Koch
Vivek P Singh
Vinicius Carreira
Nathan Robbins
Amit R Patel
Min Jiang
Philip Bidwell
Evangelia G Kranias
W Keith Jones
John N Lorenz
University of Cincinnati Medical Center · US

Funding

Cincinnati Center for Clinical and Translational Sciences and TrainingUL1TR000077 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., TSEVAT, JOEL · 2012 to 2014
$9.9M
Cardiac Sarcoplasmic Reticulum Calcium Cycling ProteinsR01HL064018 · NHLBI · UNIVERSITY OF CINCINNATI · PI KRANIAS, EVANGELIA G · 2000 to 2017
$6.8M
Paradoxical Effects of NF-kB in Ischemia; Novel Polymeric Gene Silencing in vivoR01HL091478 · NHLBI · UNIVERSITY OF CINCINNATI · PI JONES, WALTER KEITH · 2008 to 2017
$5.7M
TARGETED ABLATION AND ALTERATION OF MOUSE PHOSPHOLAMBANR01HL026057 · NHLBI · UNIVERSITY OF CINCINNATI · PI KRANIAS, EVANGELIA G · 1985 to 2017
$5.3M
Understanding Cardiovascular Disease MechanismsT32HL125204 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI Evangelia G Kranias, Jeffery D Molkentin · 2015 to 2026
$3.4M
Short Term Medical Student Training GrantT35DK060444 · NIDDK · UNIVERSITY OF CINCINNATI · PI JASON T BLACKARD · 2002 to 2026
$2.3M
NCATS NIH HHS UL1 TR000077NHLBI NIH HHS HL-64018NHLBI NIH HHS R01 HL026057NHLBI NIH HHS R01 HL064018NHLBI NIH HHS R01 HL091478NIDDK NIH HHS T35 DK060444
6 · The paper itself

Abstract

Transient receptor potential cation channels have been implicated in the regulation of cardiovascular function, but only recently has our laboratory described the vanilloid-2 subtype (TRPV2) in the cardiomyocyte, though its exact mechanism of action has not yet been established. This study tests the hypothesis that TRPV2 plays an important role in regulating myocyte contractility under physiological conditions. Therefore, we measured cardiac and vascular function in wild-type and TRPV2(-/-) mice in vitro and in vivo and found that TRPV2 deletion resulted in a decrease in basal systolic and diastolic function without affecting loading conditions or vascular tone. TRPV2 stimulation with probenecid, a relatively selective TRPV2 agonist, caused an increase in both inotropy and lusitropy in wild-type mice that was blunted in TRPV2(-/-) mice. We examined the mechanism of TRPV2 inotropy/lusitropy in isolated myocytes and found that it modulates Ca(2+) transients and sarcoplasmic reticulum Ca(2+) loading. We show that the activity of this channel is necessary for normal cardiac function and that there is increased contractility in response to agonism of TRPV2 with probenecid.

Indexed as

AnimalsCalcium ChannelsHeartHemodynamicsMiceMice, KnockoutMyocardial ContractionMyocardiumMyocytes, CardiacProbenecidSarcoplasmic ReticulumTRPV Cation ChannelsUricosuric AgentsCalcium ChannelsProbenecidTrpv2 protein, mouseTRPV Cation ChannelsUricosuric Agentsblood flowblood pressurecalciumcardiac myocytescontractilityhemodynamicsion channelsprobenecidvascular resistance

Identifiers

PMID24322617
PMCPMC3920243
OpenAlexW1964068856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.